Related Experiment Video
Updated: Apr 18, 2026
11:30
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
25.7K
Resveratrol nanoformulations: challenges and opportunities
Natalie Summerlin1, Ernest Soo1, Sachin Thakur1
1School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
International Journal of Pharmaceutics
|January 10, 2015
Summary
Resveratrol shows therapeutic promise, but poor bioavailability limits its use. Nanotechnology-based formulations (nanoformulations) offer a novel solution to enhance resveratrol
Area of Science:
- Pharmacology and Nanomedicine
- Natural Product Chemistry
Background:
- Resveratrol, a natural polyphenol, exhibits significant anticancer, antioxidant, and anti-inflammatory properties.
- Poor pharmacokinetic characteristics, including low solubility, photostability, and extensive first-pass metabolism, severely limit resveratrol's bioavailability and therapeutic efficacy.
- Conventional drug delivery systems have faced challenges in effectively formulating resveratrol.
Purpose of the Study:
- To review the therapeutic potential and mechanisms of action of resveratrol.
- To explore the pharmacokinetic limitations hindering resveratrol's clinical application.
- To discuss the advancements and challenges in developing resveratrol-loaded nanoformulations.
Main Methods:
- Comprehensive literature review of studies on resveratrol's therapeutic effects.
- Analysis of pharmacokinetic data and limitations of resveratrol.
- Evaluation of various nanotechnology-based formulations (nanoformulations) for resveratrol delivery.
Main Results:
- Nanoformulations demonstrate potential in improving resveratrol's pharmacokinetic profile, targetability, and bioavailability.
- Recent advancements in nanoparticle encapsulation techniques have shown promise.
- Challenges remain in optimizing encapsulation efficiency and clinical translation.
Conclusions:
- Nanotechnology offers a promising strategy to overcome resveratrol's bioavailability issues.
- Further research into advanced encapsulation techniques is crucial for enhancing resveratrol's clinical potential.
- Resveratrol nanoformulations represent a significant step towards realizing the full therapeutic benefits of this natural compound.
Related Concept Videos
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
338
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
338
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
314
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
314
01:19Modified-Release Drug Delivery Systems: Overview
211
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
211
01:20Modified-Release Drug Delivery Systems: Influencing Factors
179
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
179
01:30Modified-Release Drug Delivery Systems: Bioavailability
146
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
146
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
227
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
227